Safety of indocyanine green lymphography for evaluation of lymphedema

Safety of indocyanine green lymphography for evaluation of lymphedema - Indocyanine green lymphography for lymphedema

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024677

Enrollment

Registered

2016-11-02

Start date

2016-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphedema

Interventions

We carry out local injection of ICG at dorsum of foot and the inside of foot joint intra- or subcutaneously. We trace the flow of ICG with an infrared observation camera. We carry out observation of w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The person by whom lymphedema continued three months or more and written consent was got.

Exclusion criteria

Exclusion criteria: Those who have the past of hypersensitivity to iodine. Those who are judged that experimental participation is difficul by moral condition. A pregnant woman, a nursing mother. Moreover, those possible of pregnancy. The person to whom the doctor judged participation of the final examination to be unsuitable.

Design outcomes

Primary

Measure	Time frame
Check whether there are side effects (shock, nausea, blood vessel pain, fever)	—

Countries

Japan

Contacts

Public ContactTakahumi Uchibori

Nagoya City University Hospital Plastic and reconstructive surgery

uchibori83@gmail.com052-858-7514

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026